High p-hydroxyphenyllactate levels were significantly associated with hepatic steatosis in the ALT-adjusted model (Model 2; OR = 3.379, 1.307–8.734), but not in the model that was further adjusted for metabolic factors (Model 3). Here, GPT is linked to fatty liver disease.